Middle East and Africa Supraglottic Devices Market Outlook (2022-2033)

The Middle East and Africa Supraglottic Devices market size is expected to reach US$ 72.0 million by 2033 from US$ 61.3 million in 2025. The market is estimated to record a CAGR of 2.1% from 2026 to 2033.

Executive Summary and Middle East and Africa Supraglottic Devices Market Analysis:

The Middle East and Africa supraglottic devices market is witnessing steady development, driven primarily by the expansion of surgical infrastructure and the rising emphasis on airway management in emergency and critical care settings. The Gulf nations have been making significant investments in upgrading their hospitals to include new and improved anesthetics and respiratory equipment, leading to the popularity of supraglottic airway devices as a safer and more efficient alternative to endotracheal tubes for specific procedures. Moreover, enhanced knowledge amongst healthcare professionals about the advantages of using minimally invasive airway management devices has prompted their use during elective surgery and emergencies before hospital admission. Chronic respiratory disorders and trauma patients, including victims of motor vehicle accidents, are also driving the demand.

Nevertheless, the market is hindered by the unequal distribution of health services among African countries and insufficient medical professionals in remote and developing locations. Besides, cost consciousness continues to be a restraint, mainly in poor regions where reusable equipment is used more frequently than disposable ones. However, there is still a chance for growth because of reforms in the health industry and an increase in private organizations' involvement.

Middle East and Africa Supraglottic Devices Market - Strategic Insights:

Middle East and Africa Supraglottic Devices Market Segmentation Analysis:

Key segments that contributed to the derivation of the Africa Supraglottic Devices market analysis are product type, usage type, application, patient type, and end user.

• By product type, the supraglottic devices market is segmented into laryngeal mask airways, laryngeal tubes, and other product types. The laryngeal mask airways segment dominated the market in 2025.
• Based on usage type, the supraglottic devices market is classified into disposable devices and reusable devices. The disposable devices segment dominated the market in 2025.
• In terms of application, the supraglottic devices market is categorized into anesthesia, critical care, emergency medicine, and other applications. The anesthesia segment dominated the market in 2025.
• By patient type, the supraglottic devices market is bifurcated into adult and pediatric. The adult segment dominated the market in 2025.
• Based on end user, the supraglottic devices market is segmented into hospitals, ambulatory surgical centers, emergency medical services, and other end users. The hospitals segment dominated the market in 2025.

Middle East and Africa Supraglottic Devices Market Drivers and Opportunities:

Emerging Preference for Minimally Invasive Airway Systems

The Middle East and Africa supraglottic devices market is gradually shifting toward minimally invasive airway systems as healthcare providers prioritize faster, more adaptable clinical interventions. Supraglottic airway devices (SGAs) are gaining recognition for their ability to provide effective airway control in settings where rapid response is critical, particularly in emergency units and trauma care environments. Their simplified insertion process allows clinicians to stabilize patients quickly, which is especially valuable in healthcare systems managing unpredictable patient inflows and diverse case complexities.

Infrastructure variability across the region is also shaping this preference. While advanced hospitals are incorporating SGAs into routine surgical workflows, smaller and developing facilities are adopting these devices as a practical alternative to more technically demanding airway management techniques. This dual dynamic creates a broad base of demand, where both high-end and resource-limited institutions see value in devices that reduce dependency on specialized equipment and extensive procedural preparation.

Another important factor is the growing focus on infection prevention and operational resilience. Disposable supraglottic devices are increasingly viewed as a reliable solution for maintaining hygiene standards in environments where sterilization capacity may fluctuate. At the same time, newer device designs that offer better sealing and adaptability to different patient anatomies are improving clinical outcomes. These combined factors are reinforcing the region’s transition toward minimally invasive airway systems as a sustainable and scalable solution.

Improving Adoption of Simulation-Led Training Strategies

Simulation-led training strategies are an important enabler of supraglottic device adoption across the Middle East and Africa. Healthcare institutions are increasingly recognizing the need to build practical airway management skills among a broader range of healthcare workers, including those who may not specialize in anesthesiology. Simulation-based learning provides a controlled setting where clinicians can repeatedly practice SGA insertion and management, helping bridge gaps in hands-on clinical exposure.

Training initiatives are evolving to address the region’s diverse healthcare landscape. Programs often focus on scenario-based learning, where participants manage simulated emergencies such as respiratory distress or airway obstruction. This approach strengthens both technical skills and real-time decision-making, ensuring that practitioners can respond effectively under pressure. In many cases, these programs are designed to be adaptable, allowing institutions with varying levels of resources to implement training modules suited to their capabilities.

The increasing use of accessible training models is further supporting adoption. Low-cost simulators, mobile training units, and peer-led workshops are helping extend skill development opportunities beyond major hospitals to smaller facilities and remote areas. This decentralized approach is improving overall competency in airway management and encouraging consistent use of supraglottic devices. As a result, simulation-led training is not only enhancing clinical preparedness but also playing a critical role in expanding the practical use of SGAs across the region.

Middle East and Africa Supraglottic Devices Market Size and Share Analysis:

The Middle East and Africa Supraglottic Devices market demonstrates steady growth, with size and share analysis highlighting evolving trends and competitive dynamics among key players. The report evaluates important subsegments categorized within product type, usage type, application, patient type, and end user, highlighting their respective contributions to overall market performance.

By product type, the laryngeal mask airways subsegment dominated the supraglottic devices market in 2025. The dominance of laryngeal mask airways is driven by their ease of insertion, high success rate in securing the airway, reduced risk of complications compared to traditional intubation, and broad adoption in surgical and emergency settings, making them a key revenue contributor for manufacturers.

Based on usage type, the disposable devices subsegment led the market in 2025. Disposable supraglottic devices are preferred due to their reduced risk of cross-contamination, lower sterilization requirements, and convenience for high-volume clinical environments, which supports their widespread adoption across hospitals and emergency care facilities.

In terms of application, the anesthesia subsegment dominated the market in 2025. This leadership is attributed to the frequent use of supraglottic devices in elective and emergency surgical procedures, the increasing number of surgeries worldwide, and the clinical benefits of providing a safe and effective airway without the need for invasive intubation.

By patient type, the adult subsegment dominated the market in 2025. The preference for adult patients is driven by higher procedural volumes in adult surgeries, the established clinical efficacy of supraglottic devices in adult airway management, and increasing adoption in critical care and emergency settings.

Based on end user, the hospitals subsegment dominated the market in 2025. Hospitals lead due to their well-established anesthesia and critical care departments, access to advanced airway management devices, trained staff, and the capability to perform a high volume of surgical and emergency procedures requiring reliable airway management.

Middle East and Africa Supraglottic Devices Market Report Highlights:

Middle East and Africa Supraglottic Devices Market Report Coverage and Deliverables:

The "Middle East and Africa Supraglottic Devices Market Size and Forecast (2022–2033)" report provides a detailed analysis of the market covering below areas:

• Middle East and Africa Supraglottic Devices market size and forecast at regional and country levels for all market segments covered under the scope
• Middle East and Africa Supraglottic Devices market trends, as well as drivers, restraints, and opportunities
• Middle East and Africa Supraglottic Devices market analysis covering key trends, regional framework, major players, regulations, and recent developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the Middle East and Africa Supraglottic Devices market
• Detailed company profiles, including SWOT analysis

Middle East and Africa Supraglottic Devices Market Geographic Insights:

The geographical scope of the Middle East and Africa Supraglottic Devices market report is divided into: Saudi Arabia, the United Arab Emirates, Kuwait, Bahrain, Qatar, Oman, Turkiye, South Africa, Egypt, Nigeria, Algeria, and the Rest of MEA. Turkiye held the largest share in 2025.

Turkiye emerges as the country leading in the Middle East and Africa supraglottic devices market because of its highly developed healthcare infrastructure, as well as its geographical advantage as a center for medical treatment between Europe and Asia. Turkiye has achieved notable success in expanding the number of its hospitals, especially those formed through Public Private Partnership (PPP). Supraglottic devices have been steadily increasing in use not only in public hospitals but also in private hospitals, owing to the increasing demand for faster procedures.

The presence of skilled anesthesiologists and continuous medical education programs has further strengthened the adoption of these devices in clinical practice. Additionally, Turkiye’s thriving medical tourism industry plays a crucial role, as hospitals catering to international patients are more likely to use advanced and disposable supraglottic devices to maintain high standards of care and infection control. Emergency medical services in urban areas are also becoming more sophisticated, incorporating supraglottic airway devices in pre-hospital care protocols. While economic fluctuations can influence procurement patterns, the country’s strong healthcare infrastructure and increasing demand for quality care continue to support market growth.

Middle East and Africa Supraglottic Devices Market Research Report Guidance:

• The report includes qualitative and quantitative data in the Middle East and Africa Supraglottic Devices market across product type, usage type, application, patient type, end user, and geography.
• The report starts with the key takeaways (chapter 2), highlighting the key trends and outlook of the Middle East and Africa Supraglottic Devices market.
• Chapter 3 focuses on the research methodology of the study.
• Chapter 4 includes ecosystem analysis.
• Chapter 5 highlights the major industry dynamics in the Middle East and Africa Supraglottic Devices market, including factors that are driving the market, prevailing deterrents, potential opportunities, as well as future trends. Impact analysis of these drivers and restraints is also covered in this section.
• Chapter 6 discusses the Middle East and Africa Supraglottic Devices market scenario, in terms of historical market revenues, and forecast till the year 2033.
• Chapters 7 to 12 cover Middle East and Africa Supraglottic Devices market segments by product type, usage type, application, patient type, end user, and geography across Saudi Arabia, the United Arab Emirates, Kuwait, Bahrain, Qatar, Oman, Turkiye, South Africa, Egypt, Nigeria, Algeria, and Rest of MEA. They cover the market revenue, forecast, and factors driving the market.
• Chapter 13 describes the competitive analysis along with the heat map analysis for the key players operating in the market.
• Chapter 14 describes the industry landscape analysis. It provides detailed descriptions of business activities such as market initiatives, new developments, mergers, and joint ventures globally, along with a competitive landscape.
• Chapter 15 provides detailed profiles of the major companies operating in the Middle East and Africa Supraglottic Devices market. Companies have been profiled on the basis of their key facts, business descriptions, products, financial overview, SWOT analysis, and key developments.
• Chapter 16, i.e., the appendix, is inclusive of a brief overview of the company, list of abbreviations, and disclaimer.

Middle East and Africa Supraglottic Devices Market News and Key Development:

The Middle East and Africa Supraglottic Devices market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the Middle East and Africa Supraglottic Devices market are:

• In May 2023, Teleflex Incorporated (via its Global Impact Report) highlighted continued investment in expanding its airway management product portfolio and distribution footprint across emerging regions, including the Middle East & Africa, to improve access to critical care devices such as supraglottic airways.
• In June 2023, Teleflex Incorporated announced a partnership with Insighters Medical for exclusive distribution of its video laryngoscope system, strengthening Teleflex’s airway management portfolio and supporting expanded access across its EMEA (Europe, Middle East & Africa) segment, which includes MEA markets.

Key Sources Referred:

• The World Bank
• World Health Organization (WHO)
• Center for Disease Control and Prevention (CDC)
• Food and Drug Administration (FDA)
• European Database on Medical Devices (EUDAMED)
• European Society of Cardiology (ESC)
• American College of Cardiology (ACC)
• American Heart Association (AHA)
• Company Websites
• Company Annual Reports
• Company Investor Presentations